No insider purchases or sales are on record for DNA X, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 26 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | $50.9M | $93.6M | $69.8M |
| GROSS PROFIT | — | $9.9M | $19.3M | $11.6M |
| OPERATING INCOME | $-5.4M | $-3.1M | $513.0K | $-14.3M |
| NET INCOME | $-20.7M | $-33.6M | $-90.0K | $-14.1M |
| EPS (DILUTED) | -28.58 | -128.37 | -0.02 | -0.49 |
| OPERATING CASH FLOW | $-23.5M | $-8.5M | $-4.1M | $-12.4M |
| CASH | $1.3M | $5.3M | $9.4M | $13.2M |
| LONG-TERM DEBT | $5.1M | — | — | — |
No password to create and no card required. We store your email address and nothing else.